West Pharmaceutical Services Inc. (WST) Social Stream



West Pharmaceutical Services Inc. (WST): $372.28

3.12 (-0.83%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

WEST PHARMACEUTICAL SERVICES INC (WST) Price Targets From Analysts

Use the tables below to see what analysts covering WEST PHARMACEUTICAL SERVICES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 5 $515 $400 $448.75 $372.51 20.47%
2022-02-18 5 $515 $405 $455 $372.51 22.14%
2022-03-01 5 $475 $400 $438.75 $372.51 17.78%
2022-04-28 5 $475 $400 $420 $372.51 12.75%
2022-04-29 5 $410 $400 $403.75 $372.51 8.39%
2022-05-09 5 $410 $341 $387.75 $372.51 4.09%
2022-06-06 5 $410 $341 $380.25 $372.51 2.08%
2022-07-28 5 $410 $333 $378.25 $372.51 1.54%
2022-08-13 5 $400 $330 $361.25 $372.51 -3.02%
2022-10-17 4 $400 $330 $365 $372.51 -2.02%
2022-10-27 4 $385 $330 $352.5 $372.51 -5.37%
2022-10-28 5 $350 $206 $287.75 $372.51 -22.75%
2022-11-01 5 $350 $206 $272.75 $372.51 -26.78%
2022-12-02 6 $315 $206 $261.2 $372.51 -29.88%
2023-01-06 7 $315 $206 $252.666 $372.51 -32.17%
2023-01-26 7 $315 $240 $258.333 $372.51 -30.65%
2023-02-09 7 $315 $240 $260 $372.51 -30.2%
2023-02-16 7 $375 $240 $270 $372.51 -27.52%
2023-02-17 7 $375 $250 $294.166 $372.51 -21.03%
2023-02-23 7 $375 $250 $300.833 $372.51 -19.24%
2023-03-01 7 $375 $250 $313.333 $372.51 -15.89%
2023-04-11 7 $400 $250 $325 $372.51 -12.75%
2023-04-28 7 $400 $250 $332.5 $372.51 -10.74%
2023-06-06 7 $400 $250 $338.333 $372.51 -9.17%
2023-06-16 7 $405 $250 $340.833 $372.51 -8.5%
2023-07-19 7 $420 $250 $344.166 $372.51 -7.61%
2023-07-26 7 $420 $250 $355.833 $372.51 -4.48%
2023-07-28 7 $420 $250 $355 $372.51 -4.7%
2023-08-21 7 $420 $250 $356.666 $372.51 -4.25%
2023-08-29 7 $420 $250 $361.666 $372.51 -2.91%
2023-09-05 7 $440 $250 $365.833 $372.51 -1.79%
2023-09-22 7 $460 $250 $375.833 $372.51 0.89%

The Trend in the Analyst Price Target


Over the past 27 months, WST's average price target has gone up $24.23.

WST reports an average of -0.39% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-01 5 350 206 272.750 229.50 18.85%
2023-01-06 7 315 206 252.666 232.50 8.67%
2023-03-01 7 375 250 313.333 318.28 -1.55%
2023-08-16 7 420 250 356.666 397.49 -10.27%
2023-08-28 7 420 250 361.666 403.37 -10.34%

WST Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.86 4 0 3 0 0 7

The Trend in the Broker Recommendations


Over the past 30 weeks, WST's average broker recommendation rating improved by 0.57.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, WEST PHARMACEUTICAL SERVICES INC's average analyst price target is greater than 3831.65% of them.
  • In the context of stocks in the large market cap category, WEST PHARMACEUTICAL SERVICES INC's number of analysts covering the stock is higher than 294.31% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, WEST PHARMACEUTICAL SERVICES INC's upside potential (average analyst target price relative to current price) is higher than 310.59% of them.
  • In terms of how WEST PHARMACEUTICAL SERVICES INC fares relative to Rubber and Plastic Products stocks, note that its variance in analysts' estimates is lower than -1851.11% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Rubber and Plastic Products industry with the ratings most similar to WEST PHARMACEUTICAL SERVICES INC are WMS, ENTG, and NPO.

Make investment decisions regarding WST using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!